These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Prognostic and survival-related factors in patients with well-differentiated oligodendrogliomas. Maiuri F, Del Basso De Caro ML, Iaconetta G, Peca C, Esposito M, de Divitiis E. Zentralbl Neurochir; 2006 Nov; 67(4):204-9. PubMed ID: 17106834 [Abstract] [Full Text] [Related]
11. Magnetic resonance imaging volumetric assessment of the extent of contrast enhancement and resection in oligodendroglial tumors. Sankar T, Moore NZ, Johnson J, Ashby LS, Scheck AC, Shapiro WR, Smith KA, Spetzler RF, Preul MC. J Neurosurg; 2012 Jun; 116(6):1172-81. PubMed ID: 22424566 [Abstract] [Full Text] [Related]
14. Factors possibly influencing the prognosis of oligodendroglioma. Sun ZM, Genka S, Shitara N, Akanuma A, Takakura K. Neurosurgery; 1988 May; 22(5):886-91. PubMed ID: 3380278 [Abstract] [Full Text] [Related]
16. [Advances in diagnosis and treatment of oligodendrogliomas of the brain. Eighty-four surgical patients (author's transl)]. Paillas JE, Grisoli F, Hassoun J, Torres-Garcia T, De Laforte C. Sem Hop; 1982 Apr 08; 58(14):851-6. PubMed ID: 6281897 [Abstract] [Full Text] [Related]
17. Chromosome 1p/19q status combined with expression of p53 protein improves the diagnostic and prognostic evaluation of oligodendrogliomas. Xiong J, Liu Y, Wang Y, Ke RH, Mao Y, Ye ZR. Chin Med J (Engl); 2010 Dec 08; 123(24):3566-73. PubMed ID: 22166632 [Abstract] [Full Text] [Related]